We're thrilled to announce our $52.7 million commitment to breast cancer research for 2022-23! Our grants support 255 scientists at leading academic and medical institutions across 14 countries. BCRF is once again the largest private funder of breast cancer research—and metastatic breast cancer research—in the world. This year, metastatic breast cancer research comprises 41 percent of our portfolio to fund 84 projects this year alone. We're doubling down on our commitments to achieving equitable progress, and, as ever, our investments span the full spectrum of breast cancer—from prevention to treatment. Tap the link in bio to read more. https://bit.ly/3UOmZyJ